Co-Delivery of mRNA and pDNA Using Thermally Stabilized Coacervate-Based Core-Shell Nanosystems.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Nasr, Sarah SLee, Sangeun
Thiyagarajan, Durairaj
Boese, Annette
Loretz, Brigitta
Lehr, Claus-Michael
Issue Date
2021-11-13
Metadata
Show full item recordAbstract
Co-delivery of different species of protein-encoding polynucleotides, e.g., messenger RNA (mRNA) and plasmid DNA (pDNA), using the same nanocarrier is an interesting topic that remains scarcely researched in the field of nucleic acid delivery. The current study hence aims to explore the possibility of the simultaneous delivery of mRNA (mCherry) and pDNA (pAmCyan) using a single nanocarrier. The latter is based on gelatin type A, a biocompatible, and biodegradable biopolymer of broad pharmaceutical application. A core-shell nanostructure is designed with a thermally stabilized gelatin-pDNA coacervate in its center. Thermal stabilization enhances the core's colloidal stability and pDNA shielding effect against nucleases as confirmed by nanoparticle tracking analysis and gel electrophoresis, respectively. The stabilized, pDNA-loaded core is coated with the cationic peptide protamine sulfate to enable additional surface-loading with mRNA. The dual-loaded core-shell system transfects murine dendritic cell line DC2.4 with both fluorescent reporter mRNA and pDNA simultaneously, showing a transfection efficiency of 61.4 ± 21.6% for mRNA and 37.6 ± 19.45% for pDNA, 48 h post-treatment, whereas established commercial, experimental, and clinical transfection reagents fail. Hence, the unique co-transfectional capacity and the negligible cytotoxicity of the reported system may hold prospects for vaccination among other downstream applications.Citation
Pharmaceutics. 2021 Nov 13;13(11):1924. doi: 10.3390/pharmaceutics13111924.Affiliation
HIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.Publisher
MDPIJournal
PharmaceuticsPubMed ID
34834339Type
ArticleLanguage
enISSN
1999-4923ae974a485f413a2113503eed53cd6c53
10.3390/pharmaceutics13111924
Scopus Count
The following license files are associated with this item:
- Creative Commons
Related articles
- Realizing time-staggered expression of nucleic acid-encoded proteins by co-delivery of messenger RNA and plasmid DNA on a single nanocarrier.
- Authors: Nasr SS, Paul P, Loretz B, Lehr CM
- Issue date: 2024 Dec
- Retro-inverso d-peptide-modified hyaluronic acid/bioreducible hyperbranched poly(amido amine)/pDNA core-shell ternary nanoparticles for the dual-targeted delivery of short hairpin RNA-encoding plasmids.
- Authors: Gu J, Chen X, Fang X, Sha X
- Issue date: 2017 Jul 15
- Polyethylenimine-based amphiphilic core-shell nanoparticles: study of gene delivery and intracellular trafficking.
- Authors: Siu YS, Li L, Leung MF, Lee KL, Li P
- Issue date: 2012 Dec
- Well-defined star polymers for co-delivery of plasmid DNA and imiquimod to dendritic cells.
- Authors: Lin W, Hanson S, Han W, Zhang X, Yao N, Li H, Zhang L, Wang C
- Issue date: 2017 Jan 15
- Complex Coacervation-Integrated Hybrid Nanoparticles Increasing Plasmid DNA Delivery Efficiency in Vivo.
- Authors: Li Y, Humphries B, Wang Z, Lang S, Huang X, Xiao H, Jiang Y, Yang C
- Issue date: 2016 Nov 16